Replies to post #1559 on Oncolytics Biotech Inc. (ONCY)

[Grifter]

What a kick in the ol' Oncies today, eh?

It's not a bad company by any means -- real research making progress and real cash flow. Just a victim of not meeting the Nasdaq $1 mark for the period.

BUT! I'd rather go back to OTC than an RS, and that is key. Good move by the company -- that says they know the value of the shares that are out there.

BUT! We got a week for players to drive this down now -- a lot of selling today. I'll pick up more when the opp is right. It'll come back around.

[Grifter]

Good call and good Monday, BET. Very nice turnaround as we get toward Thursday and our new OTC status. Will see how the market treats us here.